* Sanara Medtech Inc SMTI.OQ SMTI.O is expected
to report
results on August 15.
* The Fort Worth Texas-based company is expected to report
revenue of $8.7 million, according to the estimate from one
analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sanara Medtech Inc
is for
a loss of 28 cents per share.
* The one available analyst rating on the shares is "buy".
* The average consensus recommendation for
the pharmaceuticals
peer group is also "Buy".
* Wall Street's median 12-month price target for Sanara
Medtech
Inc is $50, above its last closing price of $28.22.
This summary was machine generated August 12 at 23:16 GMT. All
figures in US dollars unless otherwise stated